Presence of Diabetic Retinopathy Worsens Vision-Related Quality of Life
HCPLive
FEBRUARY 2, 2024
As diabetic retinopathy severity progresses, both vision-related and health-related scales show a significant deterioration in quality of life scores.
Diabetes Dialogue: Blue Circle Health, with Monica Gomberg, MD
HCPLive
JUNE 27, 2024
Monica Gomberg, MD, joins the podcast to discuss how Blue Circle Health leverages free support and education programs to improve management and quality of life in people with types 1 diabetes.
Diabetes 
98
98 
CareDx Launches Two Expanded Indications for AlloSure Testing Services
DAIC
MARCH 14, 2025
Simultaneous pancreas-kidney (SPK) transplants are known to improve the quality of life and long-term survival of patients with insulin dependent diabetes and advanced renal disease. I have witnessed firsthand the significant benefits for patients with diabetes and kidney failure of receiving a pancreas and kidney transplant.
LX9211 Reduces Diabetic Nerve Pain, Improves Quality of Life in Phase 2 Trial
HCPLive
JUNE 23, 2024
Use of LX9211 showed significant benefits for diabetic peripheral neuropathic pain in the phase 2 RELIEF-DPN 1 trial.
Semaglutide and Walking Capacity in People With Symptomatic Peripheral Artery Disease and Type 2 Diabetes
American College of Cardiology
MARCH 29, 2025
The goal of the phase 3b STRIDE trial was to evaluate the safety of once-weekly injections of the GLP-1 receptor agonist semaglutide and to determine whether it improves function (symptoms and quality of life [QoL]) in patients with symptomatic peripheral artery disease (PAD) and type 2 diabetes (T2D) with functional limitations.
The Data For Weight Loss Medications Just Keeps Pouring In.
Dr. Paddy Barrett
FEBRUARY 21, 2025
The reason excess weight is such big issues are the health consequences it confers with increased rates of diabetes, heart disease, osteoarthritis, obstructive sleep apnea, non-alcoholic fatty liver disease and others, just to name a few. Avoiding diabetes and its precursor states inclduing insulin resistance is key. Osteoarthritis.
Obesity 81
81 
STRIDE and SOUL: Semaglutide Improves PAD Outcomes; Oral Formulation Effective
American College of Cardiology
MARCH 29, 2025
Semaglutide, compared to placebo, significantly improved walking distance, symptoms and quality of life in participants with symptomatic peripheral artery disease (PAD) and type 2 diabetes (T2D), according to results of the STRIDE study presented at ACC.25 25 in Chicago and simultaneously published in The Lancet.
Quality of Life in Elderly Diabetic Coronary Patients
The American Journal of Cardiology
JUNE 15, 2024
Publication date: Available online 15 June 2024 Source: The American Journal of Cardiology Author(s): Monique G. Davis, James C. Blankenship
New Drug Fails to Improve Diabetes-Related Heart Failure
DAIC
APRIL 9, 2024
The international ARISE-HF trial was designed to test the effectiveness of the investigational drug AT-001 at stabilizing exercise capacity in patients with diabetic cardiomyopathy. Patients had had Type 2 diabetes for an average of 14 years. Decline in exercise ability is a hallmark of progression to overt heart failure.
Quality of Life in Older Adults with Stable Ischemic Heart Disease and Diabetes Mellitus: A Post-hoc Analysis of the BARI 2D Trial
The American Journal of Cardiology
MAY 25, 2024
Publication date: Available online 24 May 2024 Source: The American Journal of Cardiology Author(s): Dae Yong Park, Yasser Jamil, Mohamad B. Moumneh, Wayne Batchelor, Michael G. Nanna, Abdulla A.
Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research in Chronic Kidney Disease at ACC.25
DAIC
MARCH 25, 2025
Additional ACC.25 Details on abstracts presented by Bayer at ACC.25 Effect of finerenone on N-terminal pro-B-type natriuretic peptide in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial during the session "Finerenone: A Promising Addition to the Armamentarium or Merely an Academic Exercise?"
Chinese herbal medicine Shenqi compound for early intervention in patients at high cardiovascular risk of type 2 diabetes mellitus: the protocol of a multicenter, randomized, double-blind, placebo-controlled trial
Frontiers in Cardiovascular Medicine
JANUARY 7, 2024
Introduction Reducing multiple cardiovascular risk factors is a key link and a challenging clinical problem to reduce the risk of cardiovascular complications and death in patients with diabetes. Currently, there is a lack of clinical studies on patients with diabetes combined with multiple risk factors.
Diabetes 45
45 
Why Walking Might Save Your Life.
Dr. Paddy Barrett
APRIL 12, 2024
Less major diseases earlier in life. Healthspan A common refrain I hear is, “ I have no interest in living longer if I do not have a good quality of life ” However, one of the single biggest factors impacting your quality of life will be whether or not you have a major chronic disease. Less diabetes.
Quality of Life 125
125 
National A-Fib Numbers Higher Than Previously Thought
DAIC
SEPTEMBER 11, 2024
A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.
Boston Scientific Receives FDA Approval for the AGENT Drug-Coated Balloon
DAIC
MARCH 1, 2024
While the stenting of coronary lesions continues to show a substantial improvement in quality of life for patients with coronary artery disease, ISR still encompasses 10 percent of percutaneous coronary interventions in the U.S. physicians the opportunity to treat their patients with this novel device."
Stents 105
105 
14 Ways To Prevent Dementia
Dr. Paddy Barrett
AUGUST 9, 2024
The 14 Factors Include: Hearing Loss High LDL cholesterol Less Education Traumatic Brain Injury Depression Social Isolation Hypertension Obesity Smoking Excess Alcohol Diabetes Physical Inactivity Air Pollution Visual Loss Dementia prevention, intervention, and care: 2024 report of the Lancet standing Commission When You Intervene Matters.
Dementia 116
116 
Exploring Obesity and the Latest Advances in Weight Loss Drugs during Healthy Weight Week
Cardiometabolic Health Congress
JANUARY 3, 2024
It increases the likelihood of developing chronic conditions such as heart disease, diabetes, and high blood pressure. Furthermore, carrying excess weight can also have detrimental effects on mental health as individuals may experience low self-esteem, body image issues, depression, and a reduced quality of life. at 36 weeks.
Obesity 97
97 
Why Exercise Is The Key To A Longer Life
Dr. Paddy Barrett
AUGUST 23, 2024
By the end of this article, you should be convinced that high levels of fitness and daily exercise are a MUST for a longer quality of life without major illness. High levels of V02 Max and aerobic fitness have also been associated with lower rates of most major chronic diseases, including cancer and diabetes. J Am Coll Cardiol.
Exercise 116
116 
New Guidelines on Peripheral Artery Disease Issued by American Heart Association, American College of Cardiology and Leading Medical Societies
DAIC
MAY 16, 2024
This plaque narrows the blood vessels and reduces blood flow to the legs and feet, which may significantly impair physical function, walking performance and quality of life. Multiple studies have shown that these programs improve functional status, walking performance and quality of life compared to usual care.
Have We Turned The Tide On Obesity?
Dr. Paddy Barrett
OCTOBER 11, 2024
For those with OSA, these therapies could be a game changer for both quality of life and, indeed, future cardiovascular risk. Patients on GLP1 therapies compared to metformin or insulin in those with diabetes had lower rates of certain cancers including 10 : Oesophageal Cancer - 40% reduction. Sci Rep 13 , 20998 (2023).
Obesity 84
84 
Tirzepatide Improves HFpEF Symptoms and Outcomes
CardiacWire
AUGUST 2, 2024
Tirzepatide has already gained FDA approval for type 2 diabetes and obesity, while achieving greater weight loss than Novo Nordisk’s semaglutide in trials. Although often referred to as a GLP-1, tirzepatide uniquely activates both GIP and GLP-1 hormone receptors.
Outcomes 59
59 
New Technology Promises to Revolutionize Valvular Heart Disease Care
DAIC
APRIL 1, 2024
Earlier detection can extend the quality of life with treatments designed to prevent progression. Valvular heart disease, a condition in which any of the heart’s four valves are damaged or diseased, afflicts 2.5 percent of all Americans and 13 percent of Americans over age 80.
Technology 105
105 
Creative Alliances in Cardiorenal Metabolic Management: A Game Changer (Part 1)
Cardiometabolic Health Congress
AUGUST 8, 2024
Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome. Engaging individuals as active participants in their care plans can significantly enhance outcomes and improve overall quality of life.
Education 59
59 
National A-Fib Numbers Higher Than Previously Tought
DAIC
SEPTEMBER 11, 2024
A-Fib, as the condition is commonly known, has been on the rise for at least the past decade, driven by the aging of the population, along with increasing rates of hypertension, diabetes and obesity. Earlier projections had estimated that 3.3 million U.S. The study appears Sept. 11 in the Journal of the American College of Cardiology JACC.
Bayer to Present New Investigational Heart Failure Data, Continued Portfolio Research
DAIC
MARCH 25, 2025
Additional ACC.25 Details on abstracts presented by Bayer at ACC.25 Effect of finerenone on N-terminal pro-B-type natriuretic peptide in heart failure with mildly reduced or preserved ejection fraction: The FINEARTS-HF trial during the session "Finerenone: A Promising Addition to the Armamentarium or Merely an Academic Exercise?"
World Health Day Puts Global Spotlight on Maternal and Newborn Health
Cardiometabolic Health Congress
APRIL 7, 2025
Toadvocate for effective investments that improve the health of mothers and infants, which may involve focusing on preventing and managing hypertension, diabetes, and heart disease during and after pregnancy. Health systems need to be able to support them across different life stages.
52 
Abstract TMP40: The Impact of Social Determinants of Health on Stroke Readmissions and Recovery
Stroke Journal
FEBRUARY 1, 2024
This will further the mandate for increased precision medicine, tailoring targeted interventions to improve the quality of life for stroke survivors. In conclusion, our preliminary study found that patients who admitted to difficulties maintaining a healthy lifestyle had a correlation with both 30-day and 30-90 day readmission.
Strokes 40
40 
Abstract WP266: The Association Between Sleep Apnea Symptoms and Depression in Stroke Survivors: Insights from the Stroke Transitions Education and Prevention (STEP) Clinic
Stroke Journal
JANUARY 30, 2025
Background:Sleep apnea symptoms, such as snoring and breathing pauses, often co-occur with depression in stroke survivors, adversely affecting recovery and quality of life. Clinically, 74.16% had hypertension, and 29.90% had diabetes. Stroke, Volume 56, Issue Suppl_1 , Page AWP266-AWP266, February 1, 2025. 10.47; p=0.001).
Education 40
40 
The Importance of Regular Heart Check-Ups: What You Need to Know
AMS Cardiology
SEPTEMBER 30, 2024
By detecting and addressing heart problems early, you can reduce your risk of serious complications and improve your quality of life. At AMS Cardiology, we are dedicated to providing the highest quality care for our patients. Regular check-ups are essential for maintaining optimal heart health.
World Stroke Day: Understanding and Combating the "Silent Killer"
ADN Center of Excellence
OCTOBER 28, 2024
For medical professionals, understanding the latest in stroke recognition and management is paramount to improving patient survival rates and quality of life post-stroke. With machine learning algorithms analyzing brain scans, healthcare providers can identify high-risk patients sooner, allowing for proactive measures.
Strokes 59
59 
Abstract TMP40: Estimates of Long-term Social Isolation Among Patients with Intracerebral Hemorrhage
Stroke Journal
JANUARY 30, 2025
Introduction:Stroke patients experience higher levels of social isolation (SI) compared to their age matched healthy cohorts which is associated with poor quality of life and increased morbidity and mortality. vs. 30.8%, p=0.001), and higher rates of diabetes (33.3% vs 12.8%, p=0.040). vs 7.7%, p=0.039) (Table 2).Conclusion:More
Hemorrhage 40
40 
The Dawn of a New Era in Cardiometabolic Health: Precision Nutrition and Omics Unveiled
Cardiometabolic Health Congress
AUGUST 2, 2024
Cardiorenal and metabolic diseases represent a complex constellation of lifestyle factors and health conditions that significantly impact longevity and quality of life. In the United States alone, an estimated 47 million people are affected by cardiorenal metabolic-related risk factors and diseases.
Diet 59
59 
Non?cardiac comorbidities and intensive up?titration of oral treatment in patients recently hospitalized for heart failure: Insights from the STRONG?HF trial
European Journal of Heart Failure
OCTOBER 4, 2023
Methods and results In the trial, eight NCCs were reported: anaemia, diabetes, renal dysfunction, severe liver disease, chronic obstructive pulmonary disease/asthma, stroke/transient ischaemic attack, psychiatric/neurological disorders, and malignancies.
Overcoming Status Quo Bias: Embracing Evidence-Based Guidelines in Cardiometabolic Care
Cardiometabolic Health Congress
AUGUST 30, 2024
Cardiometabolic diseases, encompassing cardiovascular conditions and metabolic disorders like diabetes, are among the most widespread global health challenges. Overcoming status quo bias and embracing the latest evidence-based practices are essential steps toward delivering high-quality, personalized care in cardiometabolic medicine.
Obesity in heart failure with preserved ejection fraction: Insights from the REDUCE LAP?HF II trial
European Journal of Heart Failure
DECEMBER 7, 2023
DM, diabetes mellitus; HTN, hypertension; LV, left ventricular; NP, natriuretic peptide; PCWP, pulmonary capillary wedge pressure; RV, right ventricular; SV, stroke volume. Aims Obesity is causally related to the development of heart failure with preserved ejection fraction (HFpEF) but complicates the diagnosis and treatment of this disorder.
The Management of Chronic Disease
Dr. Sanjay Gupta
MARCH 6, 2022
Pharmacological treatments: These can be divided into 2 groups Medications that improve quality of life (usually by relieving symptoms) and medications that can prolong life. Medications that improve quality of life in heart failure for example include diuretics.
Clinical Trial Results from Peerbridge Health Unveil Direct-from-ECG Sleep Apnea Detection Using COR Wearable Platform
DAIC
DECEMBER 19, 2023
This clinical trial cohort included participants aged 24 to 70, with diagnosed co-morbidities that included OSA, asthma, diabetes, obesity hypertension, Heart Failure (HF) and hyperthyroidism. Undiagnosed and untreated sleep apnea increases the risk of costly health complications like heart disease, hypertension, diabetes, and depression.
How to Prevent Peripheral Artery Disease
AMS Cardiology
NOVEMBER 4, 2023
When this occurs, the blood flow to these extremities can be significantly reduced, leading to symptoms such as leg pain, cramping and fatigue, affecting the quality of life for those suffering from this condition.
Society for Vascular Surgery Launches Campaign to Help People Maintain Vascular Health
DAIC
OCTOBER 23, 2024
Maintaining vascular health at every age supports overall health, quality of life, and longevity, yet more than seven in 10 doctors haven’t talked to their patients over the age of 50 about their risk for vascular disease, or their Strong Vessel Score [SVS Consumer Survey].
Cardiovascular Risk: What Men Need To Know
MIBHS
NOVEMBER 15, 2023
His techniques and protocols allow for excellent results and greatly improved quality of life. Obesity is associated with conditions like diabetes and sleep apnea, which further increase cardiovascular risk. Dr. Ciuffo is an expert in high-risk heart surgery cases.
WELCOME TO THE PRIMARY BANK OF ASPIRIN
Dr. Sanjay Gupta
AUGUST 31, 2022
In the same sense the best medications to take are those that are both safe but also in the long term offer a substantial return in terms of either improving quality of life and/or an improvement in length of life. Let’s look at length of life: Does Aspirin prevent death or vascular events (i.e
Heart Attack 40
40 
Top 10 Cardiac Diagnosis Trends in 2024
GEMMS
MAY 22, 2024
Much of heart disease is linked to conditions like diabetes, obesity, or chronic kidney disease, and specific mutations in nucleic acids help identify them. It ultimately aims to improve outcomes and enhance the quality of life for individuals with heart-related conditions.
Reaching the Underserved in Rural America
The Beat Blog
MAY 2, 2023
3 Access to timely quality care becomes more and more of a challenge for too many rural communities – and hospitals and payers continue to look for solutions to address this intractable problem. Early detection saves lives, improves quality of life, and enables equitable cardiovascular care regardless of location.
8 Crucial Features Your Cardiology EHR Software Should Have
GEMMS
MARCH 28, 2023
Chronic Care Management Chronic care management programs are designed to reduce symptoms, improve quality of life and prevent hospitalizations for chronic illnesses like diabetes, heart disease, arthritis, and asthma.
Patient Care 52
52 
Let's personalize your content